A detailed history of Keynote Financial Services LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Keynote Financial Services LLC holds 14,300 shares of MRK stock, worth $1.28 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares
14,300
Previous 11,987 19.3%
Holding current value
$1.28 Million
Previous $1.08 Billion 5.21%
% of portfolio
0.76%
Previous 0.77%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025

BUY
$73.47 - $87.12 $169,936 - $201,508
2,313 Added 19.3%
14,300 $1.13 Billion
Q1 2025

May 09, 2025

BUY
$83.01 - $101.02 $292,278 - $355,691
3,521 Added 41.59%
11,987 $1.08 Billion
Q4 2024

Feb 05, 2025

BUY
$96.31 - $114.76 $214,963 - $256,144
2,232 Added 35.8%
8,466 $842 Million
Q1 2024

Jun 13, 2024

BUY
$113.24 - $131.95 $705,938 - $822,576
6,234 New
6,234 $823 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $227B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Keynote Financial Services LLC Portfolio

Follow Keynote Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keynote Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keynote Financial Services LLC with notifications on news.